This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1996 Mar 20;12(5):393-8.

doi: 10.1089/aid.1996.12.393.

T cell-mediated destruction of bovine leukemia virus-infected peripheral lymphocytes by bovine leukemia virus env-vaccinia recombinant vaccine

K Ohishi¹, Y Ikawa

Affiliations

PMID: 8882317
DOI: 10.1089/aid.1996.12.393

Review

T cell-mediated destruction of bovine leukemia virus-infected peripheral lymphocytes by bovine leukemia virus env-vaccinia recombinant vaccine

K Ohishi et al. AIDS Res Hum Retroviruses. 1996.

. 1996 Mar 20;12(5):393-8.

doi: 10.1089/aid.1996.12.393.

Authors

K Ohishi¹, Y Ikawa

Affiliation

¹ Laboratory of Molecular Oncology, Tsukuba Life Science Center (RIKEN), Ibaraki, Japan.

PMID: 8882317
DOI: 10.1089/aid.1996.12.393

No abstract available

PubMed Disclaimer

Similar articles

Role of cell-mediated immunity in bovine leukemia virus (BLV) infection in ruminants: its implication for the vaccination strategy against retroviruses.
Sugimoto M, Ohishi K, Ikawa Y. Sugimoto M, et al. Ther Immunol. 1994 Oct;1(5):297-301. Ther Immunol. 1994. PMID: 7584504 Review.
Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: association with cell-mediated immunity.
Ohishi K, Suzuki H, Yamamoto T, Maruyama T, Miki K, Ikawa Y, Numakunai S, Okada K, Ohshima K, Sugimoto M. Ohishi K, et al. J Gen Virol. 1991 Aug;72 ( Pt 8):1887-92. doi: 10.1099/0022-1317-72-8-1887. J Gen Virol. 1991. PMID: 1651982
Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
Gatei MH, Naif HM, Kumar S, Boyle DB, Daniel RC, Good MF, Lavin MF. Gatei MH, et al. J Virol. 1993 Apr;67(4):1803-10. doi: 10.1128/JVI.67.4.1803-1810.1993. J Virol. 1993. PMID: 7680387 Free PMC article.
Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes.
Cherney TM, Schultz RD. Cherney TM, et al. Am J Vet Res. 1996 Jun;57(6):812-8. Am J Vet Res. 1996. PMID: 8725805 Clinical Trial.
Bovine leukemia virus, a versatile agent with various pathogenic effects in various animal species.
Burny A, Bruck C, Cleuter Y, Couez D, Deschamps J, Ghysdael J, Grégoire D, Kettmann R, Mammerickx M, Marbaix G, et al. Burny A, et al. Cancer Res. 1985 Sep;45(9 Suppl):4578s-4582s. Cancer Res. 1985. PMID: 2410107 Review.

See all similar articles

Cited by

Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV.
Rodríguez SM, Florins A, Gillet N, de Brogniez A, Sánchez-Alcaraz MT, Boxus M, Boulanger F, Gutiérrez G, Trono K, Alvarez I, Vagnoni L, Willems L. Rodríguez SM, et al. Viruses. 2011 Jul;3(7):1210-48. doi: 10.3390/v3071210. Epub 2011 Jul 19. Viruses. 2011. PMID: 21994777 Free PMC article. Review.
The Global Epidemiology of Bovine Leukemia Virus: Current Trends and Future Implications.
Lv G, Wang J, Lian S, Wang H, Wu R. Lv G, et al. Animals (Basel). 2024 Jan 18;14(2):297. doi: 10.3390/ani14020297. Animals (Basel). 2024. PMID: 38254466 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon